Get started
Author

Daria V. Bukhanova

Observed names: D V Bukhanova, D. Bukhanova, D. S. Bukhanova, D. V. BUKHANOVA, D. V. Bukhanova, D.V. Bukhanova, DV Buhanova, Daria Bukhanova, Д. В. Буханова
Institution: R-Pharm (Russia)
ORCID: 0000-0002-8591-7488
Observed ORCID: 0000-0002-8591-7488
OpenAlex ID: A5080159247
Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment
2024 · Eugen Feist, Roy M Fleischmann, et al. · Annals of the Rheumatic Diseases · 19
PDF
Comorbid infections in rheumatic diseases (according to FSBI RIR named after V.A. Nasonova)
2019 · D. V. Bukhanova, B. S. Belov, et al. · Meditsinskiy sovet = Medical Council · 15
PDF
Thu0127 Immunogenicity and Safety of 23-valent Pneumococcal Vaccine in Patients With Rheumatoid Arthritis: Results From 5-year Follow up
2019 · Daria Bukhanova, Boris Belov, et al. · Annals of the Rheumatic Diseases · 9
PDF
Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases
2018 · D. V. Bukhanova, B. S. Belov, et al. · Meditsinskiy sovet = Medical Council · 9
Fri0212 Use of 23-valent Polysaccharide Pneumococcal Vaccine in Patients With Systemic Lupus Erythematosus: the Relationship of Immunogenicity With Therapy
2019 · Galina Tarasova, Boris Belov, et al. · Annals of the Rheumatic Diseases · 7
PDF
Investigation of Immunogenicity and Safety of 23-valent Polysaccharide Pneumococcal Vaccine in Patients With Systemic Lupus Erythematosus
2018 · G. M. Tarasova, B. S. Belov, et al. · Rheumatology Science and Practice · 7
PDF
Immunogenicity and efficiency of a 23-valent pneumococcal vaccine in patients with rheumatoid arthritis: results of a 5-year follow up study
2018 · D. V. Bukhanova, M. S. Sergeeva, et al. · Modern Rheumatology Journal · 6
PDF
Joint damage in hiv positive patients
2018 · D. V. Bukhanova, B. S. Belov · Meditsinskiy sovet = Medical Council · 6
PDF
The Problem of Lower Respiratory Tract Infections in Rheumatology: Relevance and Ways of Solution
2020 · B.S. Belov, D.V. Bukhanova, et al. · Effective Pharmacotherapy · 5
PDF
Infectious comorbidities in patients with rheumatoid arthritis: Status praesens
2019 · B. S. Belov, G. M. Tarasova, et al. · Modern Rheumatology Journal · 5
PDF
Procalcitonin Testing in Rheumatology
2017 · D. V. Bukhanova, B. S. Belov, et al. · The Clinician · 5
Vaccination in rheumatology: Evolution of views on the problem
2017 · B S Belov, M S Sergeeva, et al. · Terapevticheskii arkhiv · 4
Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment
2024 · Eugen Feist, Roy M. Fleischmann, et al. · Modern Rheumatology Journal · 3
PDF
Lower respiratory tract infections in rheumatic diseases
2018 · B. S. Belov, D. V. Bukhanova, et al. · Modern Rheumatology Journal · 3
PDF
Biological Therapy and Infection in Rheumatoid Arthritis Patients: Modern Aspects
2016 · B. S. BELOV, M. S. NAUMTSEVA, et al. · Meditsinskiy sovet = Medical Council · 3
PDF
Fri0031 Assessment of Efficacy, Safety and Immunogenicity of a Trivalent Split-virus Influenza Vaccine in Patients With Rheumatic Diseases
2019 · Daria Bukhanova, Boris Belov, et al. · Annals of the Rheumatic Diseases · 2
PDF
Chikungunya fever: rheumatological aspects
2018 · В. S. Belov, D. V. Bukhanova, et al. · Modern Rheumatology Journal · 2
PDF
SAT0394 Immunogenicity and safety of 23-valent pneumococcal vaccine in ra patients: results of a 4- year follow up study
2018 · D. Bukhanova, M. Sergeeva, et al. · Annals of the Rheumatic Diseases · 2
PDF
THU0132 Immunogenicity and safety of 23-valent pneumococcal vaccine for patients with rheumatoid arthritis: results from 2-year follow up
2017 · MS Sergeeva, BS Belov, et al. · Annals of the Rheumatic Diseases · 2
PDF
Targeted Therapy and Infections in Rheumatic Diseases
2016 · B. S. Belov, M. S. Naumtseva, et al. · Modern Rheumatology Journal · 2
PDF
The impact of comorbidities on the efficacy of IL-6 inhibitor olokizumab compared to adalimumab in a randomized controlled trial
2025 · Eugen Feist, Michael E. Luggen, et al. · Arthritis Research & Therapy · 1
PDF
Results of a 24-week open-label phase II study of olokizumab in adolescent patients with polyarticular juvenile idiopathic arthritis
2024 · E.I. Alexeeva, T.M. Dvoryakovskaya, et al. · Voprosy praktičeskoj pediatrii · 1
Significance of serum procalcitonin for differentiating infections from rheumatic diseases
2018 · G. M. Tarasova, B. S. Belov, et al. · Meditsinskiy sovet = Medical Council · 1
PDF
SAT0395 Assessment of efficacy and safety of a trivalent split-virus influenza vaccine in patients with rheumatic diseases
2018 · D. Bukhanova, B. Belov, et al. · Annals of the Rheumatic Diseases · 1
PDF
SAT0397 Safety and immunogenicity of 23-valent pneumococcal vaccine in sle patients
2018 · G. Tarasova, B. Belov, et al. · Annals of the Rheumatic Diseases · 1
PDF
Works count: 39
Citation count: 124
H-index: 6
I10-index: 2
Year
Topic
Type